← Leaderboards
Christie M Ballantyne
Baylor College Of Medicine
$15,721,064
Attributed
$20,184,461
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2007–22$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$20,184,461 · 15
By mechanism
R01$15,205,012 · 6
N01$2,395,504 · 2
P01$1,255,900 · 1
P30$996,476 · 1
T32$234,755 · 1
M01$96,814 · 4
Top collaborators
- Pradeep Natarajan4 shared
- Elizabeth Selvin4 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Alan B. Lumsden$3,552,268
- William Raymond Lagor$11,150,642
- David John Tweardy$14,168,425
- Siripoom V McKay$1,817,777
- Alan Lumsden$51,398
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationAtherosclerosisEventCardiovascular SystemCytokineRisk FactorsResponseMyocardial InfarctionParticipantCohortLipidsDiabetes MellitusCardiovascular DiseasesObesityMeasurementGrantChemokineLeadPathway InteractionsDietCardiovascular Risk FactorExerciseLeukocytesClinical Trials
Grant awards (38)
Clonal hematopoiesis in humans: determinants of development and progression$1,441,860
R01 · FY2022 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,425,387
R01 · FY2021 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,470,291
R01 · FY2020 · HL · contact PI
Clonal hematopoiesis in humans: determinants of development and progression$1,532,120
R01 · FY2019 · HL · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$641,097
R01 · FY2019 · HL · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$791,271
R01 · FY2018 · HL · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$794,225
R01 · FY2017 · HL · contact PI
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease$830,544
R01 · FY2016 · HL · contact PI
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity$309,662
R01 · FY2013 · DK · contact PI
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity$320,928
R01 · FY2012 · DK · contact PI
Atherosclerosis and Vascular Biology Training Center$234,755
T32 · FY2012 · HL · contact PI
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity$320,857
R01 · FY2011 · DK · contact PI
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA$11,873
M01 · FY2011 · RR · contact PI
Atherosclerosis Risk in Communities Study (ARIC)$737,739
N01 · FY2010 · HL · contact PI
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy$499,975
P30 · FY2010 · HL · contact PI
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity$357,546
R01 · FY2010 · DK · contact PI
Obesity, Inflammation and Thrombosis: LOOK AHEAD$175,263
R01 · FY2010 · HL · contact PI
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA$21,746
M01 · FY2010 · RR · contact PI
Obesity, Inflammation and Thrombosis: LOOK AHEAD$880,360
R01 · FY2009 · HL · contact PI
Atherosclerosis Risk in Communities Study (ARIC)$873,084
N01 · FY2009 · HL · contact PI
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy$496,501
P30 · FY2009 · HL · contact PI
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity$361,079
R01 · FY2009 · DK · contact PI
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA$39,994
M01 · FY2009 · RR · contact PI
Obesity, Inflammation and Thrombosis: LOOK AHEAD$719,422
R01 · FY2008 · HL · contact PI
Obesity, Inflammation and Thrombosis: LOOK AHEAD$183,445
R01 · FY2008 · HL · contact PI
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA$23,201
M01 · FY2008 · RR · contact PI
Effect of lipid modification on peripheral arterial disease (PAD)$838,966
R01 · FY2007 · HL · contact PI
Obesity, Inflammation and Thrombosis: LOOK AHEAD$786,168
R01 · FY2007 · HL · contact PI
MAC 1/LFA 1/P150 95 AND PMN LEUKOCYTE FUNCTION$361,472
R01 · FY2002 · HL
Inflammation of reperfused heart: gene deletion$313,975
P01 · FY2002 · HL
Inflammation of reperfused heart: gene deletion$313,975
P01 · FY2002 · HL
MAC 1/LFA 1/P150 95 AND PMN LEUKOCYTE FUNCTION$345,479
R01 · FY2001 · HL
Inflammation of reperfused heart: gene deletion$313,975
P01 · FY2001 · HL
COMMUNITY AND COHORT SURVEILLANCE PROGRAM$392,812
N01 · FY2000 · HC
COMMUNITY AND COHORT SURVEILLANCE PROGRAM$391,869
N01 · FY2000 · HC
MAC 1/LFA 1/P150 95 AND PMN LEUKOCYTE FUNCTION$317,570
R01 · FY2000 · HL
Inflammation of reperfused heart: gene deletion$313,975
P01 · FY2000 · HL
COMMUNITY AND COHORT SURVEILLANCE PROGRAM$0
N01 · FY2000 · HC